Tissue Regenix Group plc Sustainability Profile
Tissue Regenix Group plc, a pioneering name in regenerative medicine, is headquartered in the United Kingdom. Founded in 2006, the company has established itself as a leader in the development of innovative tissue regeneration technologies, primarily focusing on orthopaedics and wound care. With a strong presence in Europe and North America, Tissue Regenix offers unique products such as dCELL® technology, which decellularises human and animal tissues to create scaffolds that promote natural healing. This approach not only enhances patient outcomes but also addresses the growing demand for effective regenerative solutions. Recognised for its commitment to advancing medical science, Tissue Regenix has achieved significant milestones, positioning itself as a key player in the regenerative medicine industry. The company continues to drive innovation, making strides in both product development and market expansion.
DitchCarbon Score
How does Tissue Regenix Group plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tissue Regenix Group plc's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tissue Regenix Group plc's reported carbon emissions
Tissue Regenix Group plc, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Tissue Regenix may not have established formal sustainability initiatives or targets at this time. As the industry increasingly prioritises climate action, it will be essential for the company to consider developing strategies to address carbon emissions and enhance its environmental responsibility.
How Carbon Intensive is Tissue Regenix Group plc's Industry?
How Carbon Intensive is Tissue Regenix Group plc's Location?
Tissue Regenix Group plc's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tissue Regenix Group plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
